MBX Biosciences, Inc. - MBX Net earnings per share (EPS TTM)

MBX Biosciences, Inc. (MBX) - corporate logo

MBX Biosciences Inc (MBX) has optimized peptide delivery by establishing raw material reserves and expanding its carrier network. The business focuses on therapies for endocrine pathologies, yet faces uncertainty regarding early-stage trials and a shortage of funds. This chart confirms a market price reflecting an EPS of -27.30, which is critical amid fierce competition with global leaders in the metabolic drugs segment.

MBX Bio (MBX) - Earnings per share for the last twelve months from 11/23/2025 to 11/17/2026

mbxbio.com - analytical breakdowns and key metrics (MBX)

- stock price and consensus target price:
Initial company analysis:MBX (MBX Biosciences, Inc.)
Flagship merchandise of MBX Biosciences Inc

MBX Biosciences Inc (MBX) leverages unique human capital expertise in endocrine peptides to advance its R&D projects. Mathematically, these efforts are reflected in the trailing twelve-month (TTM) earnings per share (EPS) growth relative to the previous year. This metric measures the rate of change in net yield, allowing for an assessment of the efficiency of intellectual asset capitalization. By analyzing the relative EPS YoY TTM growth rate, an investor can determine the company's stage of fundamental development.

Competitor analysis

Net earnings per one share for the last twelve months Ascendis Pharma Inc.|MDGL (Madrigal Pharmaceuticals, Inc.) - Net earnings per share for the last 12 months|CORT: Earnings per share for the last four quarters|RYTM (Rhythm Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Akero Therapeutics|Net earnings per share (EPS TTM) MTSR|Earnings per share for the last twelve months MLTX (MoonLake Immunotherapeutics AG)|Earnings per share for the last twelve months crinetics.com CRNX|NewAmsterdam Pharma Corp (NAMS) - Net earnings per one share for the last twelve months|SLNO - Earnings per share for the last twelve months|FOLD: Earnings per share for the last twelve months|ETNB: Net earnings per share (EPS TTM)|AGIO - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months rezolutebio.com (RZLT)|Net earnings per share for the last 12 months lexpharma.com LXRX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioAge Labs, Inc BIOA|Biomea Fusion Inc (BMEA) - Earnings per share for the last twelve months|QNCX - Net earnings per share for the last four quarters|GUTS (Fractyl Health Inc.) - Net earnings per share (EPS TTM)|VTVT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATPC|Net earnings per share for the last four quarters Pluri Inc|Net earnings per share (EPS TTM) SYBX (Synlogic Corp)|Net earnings per share for the last four quarters lipocine.com (LPCN)|MTNB - Earnings per share for the last twelve months|Earnings per share for the trailing year SPRB (Spruce Biosciences)|GLTO (Galecto Corp) - Net earnings per share for the last 12 months|Carmell Corp - Earnings per share for the trailing year|LUMO (Lumos Therapeutics) - Net earnings per share (EPS TTM)|ONVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) RDUS